Toshiaki WAKABAYASHI

E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition

Junji Matsui, Yuji Yamamoto, Yasuhiro Funahashi et al. · International Journal of Cancer · 2007 · 547 citations

Medicine, Oncology, Pharmacology +17

Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage

Yuji Yamamoto, Junji Matsui, Tomohiro Matsushima et al. · Vascular Cell · 2014 · 500 citations · Full text

Medicine, Oncology, Pharmacology +16

Boron nitride as a lubricant additive

Yoshitsugu Kimura, Toshiaki WAKABAYASHI, Kazumi Okada et al. · Wear · 1999 · 328 citations

Engineering, Materials Engineering, Materials Science +11

Stem Cell Factor/c-kit Signaling Promotes the Survival, Migration, and Capillary Tube Formation of Human Umbilical Vein Endothelial Cells

Junji Matsui, Toshiaki WAKABAYASHI, Makoto Asada et al. · Journal of Biological Chemistry · 2004 · 218 citations · Full text

Life Sciences, Cell Biology, Pharmacology +16

Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium.

Yasuhiro Funahashi, Naoko Hata Sugi, Taro Semba et al. · PubMed · 2002 · 102 citations

Life Sciences, Cell Biology, Pharmacology +13